Bayer said it received approval from the Food and Drug Administration for its drug Nubeqa, which treats patients with a certain type of prostate cancer.

We are living in the era of cautious consumerism. These past weeks and months have been a trying time for investors, with the stock market roiled by President Donald Trump's tariff plans and a ...

BAY CITY, MI -- Each week through the 2025 high school spring sports season, we spotlight athletes from baseball, softball, ...

U.S. stocks drifted higher and pulled closer to their record as the wait continues for more updates on President Donald Trump ...

Canada's main stock index edged up and U.S. markets climbed as investors tried to tune out the latest noise from U.S.

The comeback rally has investors increasingly confident stocks have turned a corner on tariffs, though concerns remain.

In the bond market, Treasury yields held relatively steady. The yield on the 10-year Treasury eased to 4.44% from 4.46% late ...

With a stock price of $141.22 per share, the computer-chip maker (NVDA) ended Tuesday's trading day with a $3.45 trillion valuation, according to Dow Jones Market Data, while Microsoft Corp.'s (MSFT) ...

Welcome to the Trading Day blog for Wednesday, June 4. ASX 200 to rise. First quarter GDP growth may be weaker than RBA ...

Shares of Super Micro Computer Inc. rose 4.83% to $43.19 Tuesday, on what proved to be an all-around great trading session ...

Trump’s tariffs and the trade war continue to affect global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.

The Dow Jones Industrial Average is still trading on the high side of the 200-day Exponential Moving Average (EMA) near ...